NCT00913185 is a Phase 4 clinical trial of Acne Free, Proactiv in Acne, sponsored by MedDerm Associates.

Who is sponsoring NCT00913185?

NCT00913185 is sponsored by MedDerm Associates.

What drugs are being tested in NCT00913185?

Interventions in NCT00913185: Acne Free, Proactiv.

Is NCT00913185 still recruiting?

NCT00913185 is currently completed. Last updated 23 June 2014.

Last reviewed 2014-06-23 · How we verify

NCT00913185

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acne Free vs. Proactiv for the Treatment of Moderately Severe Acne Vulgaris

Completed Phase 4 Last updated 23 June 2014

What this trial tests

Phase 4 trial testing Acne Free, Proactiv in Acne in 128 participants. Completed in 1 February 2008.

Timeline

1 December 2006

Primary endpoint
1 December 2006

1 February 2008

Quick facts

Lead sponsor	MedDerm Associates
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	128
Start date	1 December 2006
Primary completion	1 December 2006
Estimated completion	1 February 2008
Sites	1 location across United States

Drugs / interventions tested

Acne Free, Proactiv — full drug profile →

Conditions studied

Acne — all drugs for Acne →

Sponsor

MedDerm Associates — full company profile →

Who can join

Adults 13 to 45, any sex, with Acne. Healthy volunteers can join.

Sponsor's own description

The purpose of this study is to compare the effectiveness of two over the counter acne products in subjects with moderate severity acne vulgaris. The two products being compared in this study are Acne Free "Severe Acne Line" manufactured by University Medical Products, and Proactiv® manufactured by Guthy-Renker.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acne

Currently open trials in the same condition.

NCT07366229 — Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne · Phase 2 · recruiting
NCT07013747 — Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne · Phase 1, PHASE2 · recruiting
NCT06989840 — Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne · Phase 1 · recruiting
NCT07368764 — The Suitability of Tience® for Treating Acne Scars · NA · recruiting
NCT06909344 — 577-nm Diode Laser in the Treatment of Non -Inflammatory Acne · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00913185 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by MedDerm Associates
Last refreshed: 23 June 2014

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00913185.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing